SCHEMBL7044769

SCHEMBL7044769

CCCc1c(O)ccc(C=O)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 6/20 0.42
CDK1 P06493 1/20 0.38
TYR P14679 2/20 0.35
TRIM24 O15164 2/20 0.35
TRIM33 Q9UPN9 2/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
CYSLTR2 Q9NS75 1/20 0.34
CYSLTR1 Q9Y271 1/20 0.34
PRKCI P41743 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
HSP90AA1 P07900 1/20 0.33
IDO1 P14902 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3881959 0.82 CYSLTR2 (0.43) ERN1CDK1TYRTRIM24TRIM33
SCHEMBL3338705 0.79 TDP1 (0.36) ERN1CYSLTR2CYSLTR1KDM4EMEN1
SCHEMBL27892219 0.77 CA1 (0.51) ERN1CDK1TYRTRIM24TRIM33
SCHEMBL10958672 0.77 CA1 (0.40) ERN1CDK1TYRTRIM24TRIM33
SCHEMBL1842516 0.77 ERN1 (0.46) ERN1CDK1TYRTRIM24TRIM33
SCHEMBL7039083 0.76 SRD5A1 (0.43) ERN1CDK1TRIM24TRIM33CNR1
SCHEMBL7693914 0.76 CYP3A4 (0.48) CNR1CNR2PRKCIMEN1NPC1
SCHEMBL6893190 0.75 ERN1 (0.52) ERN1CDK1TRIM24TRIM33MEN1
SCHEMBL219677 0.73 ERN1 (0.54) ERN1CDK1TYRTRIM24TRIM33
SCHEMBL31300223 0.73 ERN1 (0.54) ERN1CDK1TYRTRIM24TRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed